Key Points
- Gtcr Investment Xi LLC sold 10,000,000 shares of Sotera Health on March 6 at an average price of $15.27, netting $152.7M and reducing its stake by ~43.98% to 12,735,301 shares (SEC filing).
- Sotera Health beat expectations with $0.26 EPS vs $0.24 est and $303.44M revenue, issued FY2026 guidance of $0.93–1.01 EPS, and retains a consensus "Moderate Buy" rating with a $20.43 target from analysts.
Sotera Health Company (NASDAQ:SHC - Get Free Report) Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business's stock in a transaction on Friday, March 6th. The stock was sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares in the company, valued at approximately $194,468,046.27. This represents a 43.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Sotera Health Stock Performance
NASDAQ SHC opened at $14.06 on Wednesday. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of 52.08 and a beta of 1.84. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $19.85. The stock has a fifty day simple moving average of $17.59 and a 200 day simple moving average of $16.82.
Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The firm had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The business's quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Sell-side analysts expect that Sotera Health Company will post 0.61 EPS for the current year.
Wall Street Analyst Weigh In
A number of research firms have weighed in on SHC. William Blair started coverage on shares of Sotera Health in a research report on Thursday, December 18th. They set an "outperform" rating for the company. Citigroup upped their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the company a "buy" rating in a research note on Tuesday, February 24th. Royal Bank Of Canada started coverage on shares of Sotera Health in a research report on Thursday, January 8th. They set an "outperform" rating and a $24.00 price objective for the company. Weiss Ratings restated a "hold (c-)" rating on shares of Sotera Health in a report on Monday, December 29th. Finally, Zacks Research cut shares of Sotera Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, January 30th. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.43.
Get Our Latest Stock Report on SHC
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the stock. IFP Advisors Inc grew its holdings in Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company's stock worth $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC acquired a new position in shares of Sotera Health during the fourth quarter valued at about $27,000. True Wealth Design LLC boosted its position in shares of Sotera Health by 389.3% during the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company's stock worth $32,000 after purchasing an additional 1,456 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company's stock worth $37,000 after purchasing an additional 2,935 shares in the last quarter. Finally, Versant Capital Management Inc grew its stake in shares of Sotera Health by 117.6% in the 3rd quarter. Versant Capital Management Inc now owns 2,535 shares of the company's stock valued at $40,000 after buying an additional 1,370 shares during the period. 91.03% of the stock is owned by institutional investors.
Sotera Health Company Profile
(
Get Free Report)
Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.
Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
